MVM Partners has closed its sixth healthcare fund, MVM VI, with $500m in limited partner commitments. Demand was well above the hard cap. MVM has been investing in high growth healthcare businesses since 1997.
MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
MVM invests in both private and public companies. Typical projected investment in each company is $30 to $60 million, but with capacity for larger investments.
MVM has been investing in high growth healthcare businesses since 1997. MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health. MVM invests in both private and public companies.
Source: Private Equity Wire
Can’t stop reading? Read more
Blackstone boosts hospitality portfolio with $200m Sunseeker Resort deal
Blackstone boosts hospitality portfolio with $200m Sunseeker Resort deal Blackstone Real Estate...
Apollo appoints Brian Chu to lead operational value creation platform APPS
Apollo appoints Brian Chu to lead operational value creation platform APPS Apollo Global...
TDR Capital eyes £2bn continuation deal for David Lloyd Leisure
TDR Capital eyes £2bn continuation deal for David Lloyd Leisure TDR Capital is nearing a £2bn...